Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Baltimore Marriott Waterfront

Feb 05, 2024 7:00 AM - Feb 07, 2024 6:00 PM

700 Aliceanna Street , Baltimore, MD 21202

Global Pharmacovigilance and Risk Management Strategies Conference

Register for 2 or more short courses and save $150 off your registration fee!

Early Bird Rates Expire in






Short Course: January 24, 2024 | Virtual

Short Course: February 4, 2024 | In-Person

Short Course: February 4, 2024 | In-Person

Conference: February 5-7, 2024 | In-Person

DIA's Global Pharmacovigilance and Risk Management Strategies Conference is a neutral event developed by regulators and industry experts discussing the updates, opportunities, and challenges alongside fresh problem-solving strategies that matter most to safety professionals.

Participant Testimonials

Informative, collaborative, professional, organized. – Participant

The topics are very relevant to the hot discussions going on right now in the industry, and there is a lot of cross industry experience to learn and discuss these topics. – Participant

It covers wide range of safety related topics, for all levels. And it encourages new learnings. It will give everyone an excellent opportunity to brash up skills. – Participant


Want to learn more about Global Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!


View our Exhibit Partners and explore our latest offerings

Highlights & Features

Stay in the know with what's going on at the event

Today’s Baltimore is a place where good ideas and ambition are the currency that matter most. It’s a place where art is seen as a catalyst for conversation, food as a means of connection, and history as an opportunity for education. It’s an essential destination full of inclusive neighborhoods where all visitors will feel invited, welcomed, and seen. Click here to check out all the tour guides based on your interests.

Discover Baltimore!

Who should attend?

  • Meeting Designed for

    • Drug Safety
    • Pharmacovigilance
    • Risk Management
    • Benefit-risk Assessment and Communication
    • Medical Product Safety Assessment
    • Post-Market Studies
    • Real-World Evidence Generation
    • Regulatory Affairs
    • Clinical Research
    • Data Safety Monitoring and Analysis
    • Pharmacoepidemiology
    • Medical Information
    • Medical Communications
    • Medical Affairs
    • Health Outcomes
    • Patient Engagement

Short Course or Primer

To keep you at the forefront.

Jan 24, 2024

Short Course:

Introduction to Statistics in Pharmacovigilance

Feb 04, 2024

Short Course:

Aggregate Safety Assessment Planning (ASAP) Process

Feb 04, 2024

Short Course:

Good Pharmacovigilance Practices (GVP) Operations Development – From Clinical Trial to Post Marketing

Program Committee

  • James  Buchanan, PharmD
    James Buchanan, PharmD President
    Covilance LLC, United States
  • Mariette  Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
    Bristol-Myers Squibb Company, United States
  • Barbara  Hendrickson, DrMed, MD
    Barbara Hendrickson, DrMed, MD Clinical Associate, Pediatric Infectious Diseases
    University of Chicago, United States
  • Scott  Janiczak, PharmD, MPH
    Scott Janiczak, PharmD, MPH Research Officer, Division of Pharmacovigilance, OSE, CDER
    FDA, United States
  • Mamiko  Konishi
    Mamiko Konishi Executive Director, Global PV Management Dept., Global Safety HQs
    Eisai Co., Ltd., Japan
  • Susan  Kindig, JD, MD
    Susan Kindig, JD, MD Executive Director, Medical & Drug Safety
    Halozyme, United States
  • Mengchun  Li, MD, MPA
    Mengchun Li, MD, MPA Senior Director, Clinical Research, Infectious Disease
    Merck & Co., Inc., United States
  • Joseph  Paradis, PharmD
    Joseph Paradis, PharmD Associate Director for Medication Error and Risk Management Initiatives, CDER
    FDA, United States
  • Mark  Perrott, PhD
    Mark Perrott, PhD Managing Partner
    Axian Consulting Limited, United Kingdom
  • Sarah  Vaughan
    Sarah Vaughan Head of Vigilance Operations
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • Yijing (Hellen)  Zhang
    Yijing (Hellen) Zhang Executive Director, Global Patient Safety
    Beigene, China
  • Jeremy  Jokinen, PhD, MS
    Jeremy Jokinen, PhD, MS Vice President and Head, Global Risk Management and International Patient Safety
    Bristol-Myers Squibb Company, United States
  • Annette S. Williams, MBA, RPh
    Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
    IQVIA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.